Pricing Log in Create free account

REGENXBIO Inc. (RGNX) vs Valneva SE Sponsored ADR (VALN)

REGENXBIO Inc. and Valneva SE Sponsored ADR are both Biotechnology companies. REGENXBIO Inc. and Valneva SE Sponsored ADR are of similar size ($558.4M and $508.5M). REGENXBIO Inc. has negative trailing earnings, so its P/E is not meaningful; Valneva SE Sponsored ADR trades at 61.6×. REGENXBIO Inc. grew revenue faster over the last twelve months: −4.59% against −53.2%. Valneva SE Sponsored ADR has the higher net margin (−12.0% vs −113.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Valneva SE Sponsored ADR leads on 10 and REGENXBIO Inc. on 7.

Valuation

Metric RGNX VALN Biotechnology median
P/E n/m 61.60 10.96
P/S 3.29 3.14 9.52
P/B 3.42 5.47 2.23
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m 44.11 0.68
EV/Sales 1.69 3.59 9.00
Earnings yield (41.47%) 1.62% (32.09%)
Free cash flow yield (30.61%) (11.42%) (22.62%)

Profitability

Metric RGNX VALN Biotechnology median
Gross margin 87.54% 38.28% 68.51%
Operating margin (95.68%) 13.56% 0.00%
Net margin (113.85%) (12.01%) 0.00%
Free cash flow margin (100.58%) 0.00% 0.00%
Return on equity (113.24%) 0.00% (50.12%)
Return on assets (35.36%) 0.00% (45.12%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric RGNX VALN Biotechnology median
Revenue growth (TTM) (4.59%) (53.16%) 6.78%
EPS growth (last fiscal year) 18.08% (805.88%) 29.88%
Revenue growth, 5-year CAGR 1.97% 9.41% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RGNX VALN Biotechnology median
Debt to equity 0.00 2.27 0.00
Current ratio 4.74 2.16 4.74
Net debt to EBITDA 1.58 (1.15) 1.01

Dividend

Metric RGNX VALN Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric RGNX VALN Biotechnology median
Market cap 508.48m 558.41m 166.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack